New Zealand markets close in 4 hours 1 minute
  • NZX 50

    12,667.92
    -56.37 (-0.44%)
     
  • NZD/USD

    0.6816
    -0.0007 (-0.10%)
     
  • NZD/EUR

    0.6014
    +0.0003 (+0.05%)
     
  • ALL ORDS

    7,508.70
    -49.10 (-0.65%)
     
  • ASX 200

    7,194.30
    -41.60 (-0.57%)
     
  • OIL

    66.32
    +0.75 (+1.14%)
     
  • GOLD

    1,784.00
    -0.30 (-0.02%)
     
  • NASDAQ

    15,877.72
    -258.21 (-1.60%)
     
  • FTSE

    7,168.68
    +109.23 (+1.55%)
     
  • Dow Jones

    34,022.04
    -461.68 (-1.34%)
     
  • DAX

    15,472.67
    +372.54 (+2.47%)
     
  • Hang Seng

    23,658.92
    +183.66 (+0.78%)
     
  • NIKKEI 225

    27,935.62
    +113.86 (+0.41%)
     
  • NZD/JPY

    76.9070
    -0.2630 (-0.34%)
     

Global Pharmacokinetics Services Market to Reach $1.3 Billion by 2027

·10-min read

Abstract: - Global Pharmacokinetics Services Market to Reach $1. 3 Billion by 2027. - Amid the COVID-19 crisis, the global market for Pharmacokinetics Services estimated at US$804.

New York, Sept. 08, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Pharmacokinetics Services Industry" - https://www.reportlinker.com/p06032497/?utm_source=GNW
5 Million in the year 2020, is projected to reach a revised size of US$1.3 Billion by 2027, growing at aCAGR of 6.9% over the period 2020-2027. Small Molecules, one of the segments analyzed in the report, is projected to record 6.5% CAGR and reach US$948.3 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Large Molecules segment is readjusted to a revised 8% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $237.6 Million, While China is Forecast to Grow at 6.4% CAGR
- The Pharmacokinetics Services market in the U.S. is estimated at US$237.6 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$224.5 Million by the year 2027 trailing a CAGR of 6.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.4% and 5.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.7% CAGR.

- Select Competitors (Total 34 Featured) -

  • Biologics Consulting Group, Inc.

  • Certara L.P.

  • Charles River Laboratories International, Inc.

  • Creative Bioarray

  • Eurofins Scientific, Inc.

  • Evotec AG

  • Frontage Labs

  • GVK Biosciences Private Limited

  • LGC Limited

  • Pacific BioLabs

  • Parexel International Corporation

  • Pharmaceutical Product Development, LLC

  • Product Development, LLC (Jaguar Holding Company I, LLC)

  • SGS SA

  • Shanghai Medicilon Inc.




Read the full report: https://www.reportlinker.com/p06032497/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Pharmacokinetics
Services by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 2: World Historic Review for Pharmacokinetics Services by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 3: World 15-Year Perspective for Pharmacokinetics
Services by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Small Molecules by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 5: World Historic Review for Small Molecules by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 6: World 15-Year Perspective for Small Molecules by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Large Molecules by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 8: World Historic Review for Large Molecules by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 9: World 15-Year Perspective for Large Molecules by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 10: USA Current & Future Analysis for Pharmacokinetics
Services by Drug Type - Small Molecules and Large Molecules -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 11: USA Historic Review for Pharmacokinetics Services by
Drug Type - Small Molecules and Large Molecules Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 12: USA 15-Year Perspective for Pharmacokinetics Services
by Drug Type - Percentage Breakdown of Value Sales for Small
Molecules and Large Molecules for the Years 2012, 2020 & 2027

CANADA
Table 13: Canada Current & Future Analysis for Pharmacokinetics
Services by Drug Type - Small Molecules and Large Molecules -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 14: Canada Historic Review for Pharmacokinetics Services
by Drug Type - Small Molecules and Large Molecules Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 15: Canada 15-Year Perspective for Pharmacokinetics
Services by Drug Type - Percentage Breakdown of Value Sales for
Small Molecules and Large Molecules for the Years 2012, 2020 &
2027

JAPAN
Table 16: Japan Current & Future Analysis for Pharmacokinetics
Services by Drug Type - Small Molecules and Large Molecules -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 17: Japan Historic Review for Pharmacokinetics Services
by Drug Type - Small Molecules and Large Molecules Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 18: Japan 15-Year Perspective for Pharmacokinetics
Services by Drug Type - Percentage Breakdown of Value Sales for
Small Molecules and Large Molecules for the Years 2012, 2020 &
2027

CHINA
Table 19: China Current & Future Analysis for Pharmacokinetics
Services by Drug Type - Small Molecules and Large Molecules -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 20: China Historic Review for Pharmacokinetics Services
by Drug Type - Small Molecules and Large Molecules Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 21: China 15-Year Perspective for Pharmacokinetics
Services by Drug Type - Percentage Breakdown of Value Sales for
Small Molecules and Large Molecules for the Years 2012, 2020 &
2027

EUROPE
Table 22: Europe Current & Future Analysis for Pharmacokinetics
Services by Geographic Region - France, Germany, Italy, UK and
Rest of Europe Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2020 through 2027 and % CAGR

Table 23: Europe Historic Review for Pharmacokinetics Services
by Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 24: Europe 15-Year Perspective for Pharmacokinetics
Services by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK and Rest of Europe Markets
for Years 2012, 2020 & 2027

Table 25: Europe Current & Future Analysis for Pharmacokinetics
Services by Drug Type - Small Molecules and Large Molecules -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 26: Europe Historic Review for Pharmacokinetics Services
by Drug Type - Small Molecules and Large Molecules Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 27: Europe 15-Year Perspective for Pharmacokinetics
Services by Drug Type - Percentage Breakdown of Value Sales for
Small Molecules and Large Molecules for the Years 2012, 2020 &
2027

FRANCE
Table 28: France Current & Future Analysis for Pharmacokinetics
Services by Drug Type - Small Molecules and Large Molecules -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 29: France Historic Review for Pharmacokinetics Services
by Drug Type - Small Molecules and Large Molecules Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 30: France 15-Year Perspective for Pharmacokinetics
Services by Drug Type - Percentage Breakdown of Value Sales for
Small Molecules and Large Molecules for the Years 2012, 2020 &
2027

GERMANY
Table 31: Germany Current & Future Analysis for
Pharmacokinetics Services by Drug Type - Small Molecules and
Large Molecules - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 32: Germany Historic Review for Pharmacokinetics Services
by Drug Type - Small Molecules and Large Molecules Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 33: Germany 15-Year Perspective for Pharmacokinetics
Services by Drug Type - Percentage Breakdown of Value Sales for
Small Molecules and Large Molecules for the Years 2012, 2020 &
2027

ITALY
Table 34: Italy Current & Future Analysis for Pharmacokinetics
Services by Drug Type - Small Molecules and Large Molecules -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 35: Italy Historic Review for Pharmacokinetics Services
by Drug Type - Small Molecules and Large Molecules Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 36: Italy 15-Year Perspective for Pharmacokinetics
Services by Drug Type - Percentage Breakdown of Value Sales for
Small Molecules and Large Molecules for the Years 2012, 2020 &
2027

UNITED KINGDOM
Table 37: UK Current & Future Analysis for Pharmacokinetics
Services by Drug Type - Small Molecules and Large Molecules -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 38: UK Historic Review for Pharmacokinetics Services by
Drug Type - Small Molecules and Large Molecules Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 39: UK 15-Year Perspective for Pharmacokinetics Services
by Drug Type - Percentage Breakdown of Value Sales for Small
Molecules and Large Molecules for the Years 2012, 2020 & 2027

REST OF EUROPE
Table 40: Rest of Europe Current & Future Analysis for
Pharmacokinetics Services by Drug Type - Small Molecules and
Large Molecules - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 41: Rest of Europe Historic Review for Pharmacokinetics
Services by Drug Type - Small Molecules and Large Molecules
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 42: Rest of Europe 15-Year Perspective for
Pharmacokinetics Services by Drug Type - Percentage Breakdown
of Value Sales for Small Molecules and Large Molecules for the
Years 2012, 2020 & 2027

ASIA-PACIFIC
Table 43: Asia-Pacific Current & Future Analysis for
Pharmacokinetics Services by Drug Type - Small Molecules and
Large Molecules - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 44: Asia-Pacific Historic Review for Pharmacokinetics
Services by Drug Type - Small Molecules and Large Molecules
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 45: Asia-Pacific 15-Year Perspective for Pharmacokinetics
Services by Drug Type - Percentage Breakdown of Value Sales for
Small Molecules and Large Molecules for the Years 2012, 2020 &
2027

REST OF WORLD
Table 46: Rest of World Current & Future Analysis for
Pharmacokinetics Services by Drug Type - Small Molecules and
Large Molecules - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 47: Rest of World Historic Review for Pharmacokinetics
Services by Drug Type - Small Molecules and Large Molecules
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 48: Rest of World 15-Year Perspective for
Pharmacokinetics Services by Drug Type - Percentage Breakdown
of Value Sales for Small Molecules and Large Molecules for the
Years 2012, 2020 & 2027

IV. COMPETITION
Total Companies Profiled: 34
Read the full report: https://www.reportlinker.com/p06032497/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting